Status:
NO_LONGER_AVAILABLE
Expanded Access for KHK2455
Lead Sponsor:
Kyowa Kirin, Inc.
Collaborating Sponsors:
University of New Mexico Cancer Center
Conditions:
Glioblastoma Multiforme
Brief Summary
This is an expanded access program for eligible participants. This program is designed to provide access to KHK2455 in combination with Mogamulizumab prior to the approval by the local regulatory agen...
Eligibility Criteria
Inclusion
- \-
Exclusion
- \-
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04321694
Last Update
April 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.